Uncover key drivers, emerging technologies, and competitive movements shaping the celiac disease treatment market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Celiac Disease Treatment Market covering 2026–2035?
The celiac disease treatment market size has experienced significant expansion in recent years. It is projected to increase from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. The growth observed in the historic period can be attributed to factors such as limited pharmacological treatment options, the prevailing reliance on gluten-free diet management, increasing diagnosis rates, rising awareness of autoimmune disorders, and an expansion in diagnostic testing availability.
The celiac disease treatment market is projected to experience robust expansion over the coming years. This market is set to reach $1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by several factors, including the emergence of non-dietary therapeutic alternatives, the broadening of enzyme and immunotherapy pipelines, the escalating worldwide occurrence of celiac disease, enhanced diagnostic precision, and heightened healthcare expenditure on chronic autoimmune conditions. Key tendencies observed during this projection period encompass a greater uptake of gluten-free dietary management, an increase in the development of enzyme-based treatments, a heightened emphasis on early detection and screening, the diversification of nutritional supplement-based therapies, and improved patient understanding and education about the disease.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Celiac Disease Treatment Market?
The increasing prevalence of diabetes is anticipated to drive the expansion of the celiac disease treatment market. Diabetes is a persistent medical condition where the body cannot properly regulate its blood sugar or glucose levels. The rising occurrence of diabetes is attributed to common dietary management needs, as both diabetes and celiac disease demand precise control over food intake to manage blood sugar and avert complications. Celiac disease treatment assists diabetes by advocating a gluten-free diet, which can enhance overall digestive health and nutrient absorption. This contributes to better blood sugar control and fewer complications for individuals handling both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, approximately 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Thus, the escalating prevalence of diabetes is propelling the growth of the celiac disease treatment market.
What Segments Are Identified Within The Structure Of The Celiac Disease Treatment Market?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies
What Trends Are Reshaping The Dynamics Of The Celiac Disease Treatment Market?
Leading enterprises within the celiac disease treatment market are concentrating on creating oral treatments, including small molecule therapies. These are designed to offer specific relief by inhibiting immune reactions to gluten, enhancing patient compliance, and providing options beyond strict gluten-free regimens. Small molecule therapies represent minute pharmaceuticals capable of readily penetrating cells to target and address proteins or enzymes responsible for illness. For example, Immunic Inc., a US-based biotechnology firm, introduced IMU-856 in February 2025. This small molecule functions by elevating endogenous glucagon-like peptide-1 (GLP-1) levels, which contributes to improved intestinal barrier function in individuals with celiac disease. Furthermore, it boosts nutrient absorption and lessens symptoms without suppressing the immune system.
Which Major Industry Participants Are Leading The Celiac Disease Treatment Market Growth?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Celiac Disease Treatment Market?
North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Celiac Disease Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp
Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company
Constipation Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model